AQR Capital Management
ATOS icon

AQR Capital Management’s Atossa Therapeutics ATOS Stock Holding History

AQR Capital Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,222
Closed -$40.1K – 3468
2025
Q2 		$40.1K Buy
3,222
+2,139
+198% +$25.6K ﹤0.01% 3249
2025
Q1 		$10.9K Buy
+1,083
New +$13.1K ﹤0.01% 3143
2022
Q3 		– Sell
-5,289
Closed -$86K – 2195
2022
Q2 		$86K Sell
5,289
-5,835
-52% -$91.9K ﹤0.01% 2104
2022
Q1 		$209K Sell
11,124
-661
-6% -$13.4K ﹤0.01% 2050
2021
Q4 		$283K Buy
11,785
+9,573
+433% +$350K ﹤0.01% 1998
2021
Q3 		$108K Buy
+2,212
New +$129K ﹤0.01% 2198

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return